06.23.21
Lina Khan was sworn in as Chair of the Federal Trade Commission on June 15, 2021.
The medical director of Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19.
A panel of the National Advertising Review Board has recommended that Colgate-Palmolive Company discontinue the claim that Colgate Optic White Renewal toothpaste “removes 10 years of yellow stains”.
In another decision involving teeth whitening claims, the National Advertising Division of BBB National Programs determined that The Procter & Gamble Company substantiated claims that its Crest Whitening Emulsions provides “better” or “100% whiter” results.
04.21.21
The Federal Trade Commission (FTC) and the Department of Justice (DOJ) have filed the first case under the COVID-19 Consumer Protection Act, a law passed by Congress in December 2020 that imposes financial penalties on violators.
The Federal Trade Commission (FTC or Commission) staff has issued a report highlighting the agency’s ongoing efforts to protect consumers during the COVID-19 pandemic.
Cough relief claims for Zarbee’s, Inc., cough products were challenged by a competitor, Maty’s Healthy Products, LLC, with the National Advertising Division (NAD) of BBB National Programs.
04.08.21
Section 230 of the Communications Decency Act (CDA) is once again at the center of a major political debate, with momentum building for an overhaul of the statute that many view as having served a critical role in the rise of big tech and social media.
03.18.21
In a major move to expand into the influencer market and bring more clarity to influencer-produced advertising content, the Screen Actors Guild-American Federation of Television and Radio Artists and the Joint Policy Committee agreed to a new Waiver for Influencer Produced Sponsored Content.
02.24.21
In a recent decision, the National Advertising Division (NAD) determined that Nanoceutical Solutions Inc. had failed to adequately substantiate efficacy and establishment claims for its product Nano Glutathione.